Nobel Prize 2026: How JNU scientist Suneel Kateriya helped lay the groundwork for optogenetics
JNU professor Suneel Kateriya's doctoral research in Germany, identifying light-sensing genes in a single-celled alga, formed a crucial foundation for optogenetics, the technology recognized by the 2026 Nobel Prize in Physiology or Medicine.
Intelligence analysis by Gemini 2.5 Flash
The 2026 Nobel Prize in Physiology or Medicine honored optogenetics, a technique for controlling cells with light. Indian scientist Suneel Kateriya, during his PhD in Germany in 2001, discovered two light-sensing proteins, channelrhodopsin-1 and channelrhodopsin-2, in the alga Chlamydomonas, which were pivotal to this groundbreaking technology.
Imagine you have a tiny light switch inside your brain cells. A scientist named Suneel Kateriya helped discover the basic parts of these switches by studying a tiny green plant called an alga. Now, scientists can put these light switches into specific brain cells, and by shining a special light, they can turn those cells on or off, helping them understand how our brains work or even fix problems like blindness.
Analysis
Suneel Kateriya
Suneel Kateriya, currently a professor at Jawaharlal Nehru University (JNU), played a foundational role in the development of optogenetics through his doctoral research in Germany. In 2001, while working in Professor Peter Hegemann's laboratory, Kateriya embarked on a fundamental quest to understand how the single-celled alga Chlamydomonas senses light and to identify the genes responsible.
His diligent work led to the identification of two crucial light-sensing proteins, later named channelrhodopsin-1 and channelrhodopsin-2. These discoveries, published in Science in 2002 and PNAS in 2003, were not initially conceived for neurological applications but rather to answer basic biological questions about algal light perception. Kateriya's contribution is described as part of a broader collaborative effort, emphasizing the importance of fundamental science and academic excellence for major innovations.
Optogenetics
Optogenetics is a revolutionary technique that enables researchers to precisely control specific cells, including neurons, using light. The core mechanism involves introducing light-sensitive proteins, such as the channelrhodopsins discovered by Kateriya, into target cells. When light is shone on these cells, the proteins act as molecular gates, opening to alter the cell's electrical activity.
This precision is a significant advancement over older methods of brain stimulation, which often affected multiple cell types across a broad region. As explained by Professor Nishith Gupta of BITS Pilani and Dr. Santhosh Sethuramanujam of IIT Madras, optogenetics allows for the selection of particular neuron populations and their control on a millisecond timescale, mirroring the brain's natural communication speed. This capability has profoundly impacted neuroscience, enabling scientists to study neural circuits with unprecedented accuracy, linking specific neurons to behaviors like learned fear responses in animals.
Retinitis Pigmentosa
Beyond its role as a research tool, optogenetics has begun to transition into early-stage clinical applications, with promising results in areas like vision restoration. The article highlights a 2021 trial involving a patient with retinitis pigmentosa, a degenerative eye disease. In this trial, the patient received a gene carrying a channelrhodopsin called ChrimsonR.
Special goggles were then used to project light onto the treated retina, allowing the patient to perceive, locate, count, and touch objects. While this represented a partial recovery rather than a full restoration of normal sight, it demonstrated the therapeutic potential of optogenetics. The retina is particularly amenable to this technology due to its accessibility for both gene delivery and light application, making blindness one of the furthest along conditions in optogenetic clinical development.
Key points
- JNU professor Suneel Kateriya's PhD research in Germany identified light-sensing genes (channelrhodopsin-1 and -2) in the alga *Chlamydomonas* in 2001.
- This discovery laid crucial groundwork for optogenetics, a technique that uses light to control specific cells, including neurons.
- The 2026 Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for the discovery of light-gated ion channels and optogenetics.
- Optogenetics allows scientists to study neural circuits with millisecond precision, linking specific neurons to behaviors.
- The technology has shown early clinical promise, with a 2021 trial demonstrating partial vision recovery in a patient with retinitis pigmentosa using channelrhodopsin and special goggles.
The foundational work on optogenetics, partly laid by Suneel Kateriya, promises significant advancements in neuroscience, allowing for unprecedented precision in studying brain function. This technology holds immense potential for developing targeted therapies for various neurological conditions, as demonstrated by early successes in treating retinitis pigmentosa.
Despite its promise, optogenetics faces considerable challenges in clinical application, including ensuring effective and safe gene delivery to target cells, achieving long-term safety, and precisely targeting cells deep within the brain. The need for specific light intensity and the invasive nature of some procedures also present hurdles for widespread therapeutic use.
